Skip to main content
SpringerLink
Log in

Endothelium-Derived Nitric Oxide: Pharmacology and Relationship to the Actions of Organic Nitrate Esters

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

Abstract

Vascular smooth muscle relaxation elicited by various endogenous substances results from their interaction with vascular endothelial cells to trigger the formation of endothelium-derived relaxing factor (EDRF). EDRF from pulmonary and peripheral arteries and veins and from cultured and freshly harvested aortic endothelial cells has been identified pharmacologically and chemically as nitric oxide (NO) or a labile nitroso compound. Endothelium-derived NO (EDNO) and authentic NO activate the cytoplasmic form of guanylate cyclase by heme-dependent mechanisms and thereby stimulate intra-cellular cyclic GMP accumulation in cells including vascular smooth muscle and platelets. Cyclic GMP functions as a second messenger to cause vascular smooth muscle relaxation and inhibition of platelet aggregation and adhesion to vascular endothelial surfaces. EDNO is synthesized from L-arginine and perhaps arginine-containing peptides by an unidentified calcium-requiring process coupled to the occupation of extracellular endothelial receptors. The biological actions of EDNO are terminated by spontaneous oxidation to NO2 − and NO3 −. The biological half-life of the very lipophilic EDNO is only 3–5 sec and this allows EDNO to function locally as an autacoid. Nitroglycerin and other organic nitrate esters elicit endothelium-independent relaxation after entering vascular smooth muscle cells and undergoing denitration and formation of NO. The pharmacological actions of nitroglycerin are therefore essentially the same as those of EDNO, and the endogenous NO receptor is the heme group bound to soluble guanylate cyclase. EDNO may serve a biological role to modulate local blood flow and platelet function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. R. F. Furchgott and J. V. Zawadzki. Nature (Lond.) 288:373–376 (1980).

    Google Scholar 

  2. R. F. Furchgott. Circ. Res. 53:557–573 (1983).

    Google Scholar 

  3. P. D. Cherry, R. F. Furchgott, J. V. Zawadzki, and D. Jothianandan. Proc. Natl. Acad. Sci. USA 72:2106–2110 (1982).

    Google Scholar 

  4. H. Azuma, M. Ishikawa, and S. Sekizaki. Br. J. Pharmacol. 88:411–415 (1986).

    Google Scholar 

  5. C. A. Gruetter, B. K. Barry, D. B. McNamara, D. Y. Gruetter, P. J. Kadowitz, and L. J. Ignarro. J. Cyclic Nucleotide Res. 5:211–224 (1979).

    Google Scholar 

  6. B. T. Mellion, L. J. Ignarro, E. H. Ohlstein, E. G. Pontecorvo, A. L. Hyman, and P. J. Kadowitz. Blood 57:946–955 (1981).

    Google Scholar 

  7. J. Diamond and K. S. Blisard. Mol. Pharmacol. 12:688–692 (1976).

    Google Scholar 

  8. S. Katsuki, W. Arnold, C. Mittal, and F. Murad. J. Cyclic Nucleotide Res. 3:23–35 (1977).

    Google Scholar 

  9. W. P. Arnold, C. K. Mittal, S. Katsuki, and F. Murad. Proc. Natl. Acad. Sci. USA 74:3203–3207 (1977).

    Google Scholar 

  10. K. D. Schultz, K. Schultz, and G. Schultz. Nature (Lond.) 265:750–751 (1977).

    Google Scholar 

  11. E. Bohme, H. Graf, and G. Schultz. Adv. Cyclic Nucleotide Res. 9:131–143 (1978).

    Google Scholar 

  12. L. J. Ignarro. FASEB J. 3:31–36 (1989).

    Google Scholar 

  13. L. J. Ignarro, R. E. Byrns, and K. S. Wood. In P. M. Vanhoutte (ed.), Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium, Raven Press, New York, 1988, pp. 427–435.

    Google Scholar 

  14. R. F. Furchgott. In P. M. Vanhoutte (ed.), Vasodilatation: Vascular Smooth Muscle, Peptides, Autonomic Nerves, and Endothelium, Reven Press, New York, 1988, pp. 401–414.

    Google Scholar 

  15. R. M. J. Palmer, A. G. Ferrige, and S. Moncada. Nature (Lond.) 327:524–526 (1987).

    Google Scholar 

  16. L. J. Ignarro, G. M. Buga, K. S. Wood, R. E. Byrns, and C. Chaudhuri. Proc. Natl. Acad. Sci. USA 84:9265–9269 (1987).

    Google Scholar 

  17. L. J. Ignarro, R. E. Byrns, G. M. Buga, and K. S. Wood. Circ. Res. 61:866–879 (1987).

    Google Scholar 

  18. R. M. J. Palmer, D. S. Ashton, and S. Moncada. Nature (Lond.) 333:664–666 (1988).

    Google Scholar 

  19. M. A. Marletta, P. S. Yoon, R. Iyengar, C. D. Leaf, and J. S. Wishnok. Biochemistry 27:8706–8711 (1988).

    Google Scholar 

  20. T. J. Rimele, R. J. Sturm, L. M. Adams, D. E. Henry, R. J. Heaslip, B. M. Weichman, and D. Grimes. J. Pharmacol. Exp. Ther. 245:102–111 (1988).

    Google Scholar 

  21. R. F. Furchgott. Annu. Rev. Pharmacol. Toxicol. 24:175–197 (1984).

    Google Scholar 

  22. T. M. Griffith, D. H. Edwards, M. J. Lewis, A. C. Newby, and A. H. Henderson. Nature (Lond.) 308:645–647 (1984).

    Google Scholar 

  23. T. M. Griffith, A. H. Henderson, D. H. Edwards, and M. J. Lewis. J. Physiol. 351:13–24 (1984).

    Google Scholar 

  24. H. A. Singer and M. J. Peach. Hypertension 4:II19–II25 (1982).

    Google Scholar 

  25. D. D. Ku and H. S. Ann. J. Pharmacol. Exp. Ther. 241:961–966 (1987).

    Google Scholar 

  26. L. J. Ignarro, R. G. Harbison, K. S. Wood, and P. J. Kadowitz. J. Pharmacol. Exp. Ther. 237:893–900 (1986).

    Google Scholar 

  27. U. Forstermann, A. Mulsch, E. Bohme, and R. Busse. Circ. Res. 58:531–538 (1986).

    Google Scholar 

  28. L. J. Ignarro. Circ. Res. (in press).

  29. L. J. Ignarro, T. M. Burke, K. S. Wood, M. S. Wolin, and P. J. Kadowitz. J. Pharmacol. Exp. Ther. 228:682–690 (1984).

    Google Scholar 

  30. W. Martin, G. M. Villani, D. Jothianandan, and R. F. Furchgott. J. Pharmacol. Exp. Ther. 232:708–716 (1985).

    Google Scholar 

  31. G. M. Rubanyi, R. R. Lorenz, and P. M. Vanhoutte. Am. J. Physiol. 249:H95–H101 (1985).

    Google Scholar 

  32. G. M. Rubanyi and P. M. Vanhoutte. Am. J. Physiol. 250: H822–H827 (1986).

    Google Scholar 

  33. S. Moncada, P. M. J. Palmer, and R. J. Gryglewski. Proc. Natl. Acad. Sci. USA 83:9164–9168 (1986).

    Google Scholar 

  34. R. M. J. Palmer, D. S. Ashton, and S. Moncada. Nature (Lond.) 333:664–666 (1988).

    Google Scholar 

  35. H. H. H. W. Schmidt, M. M. Klein, F. Niroomand, and E. Bohme. Eur. J. Pharmacol. 148:293–295 (1988).

    Google Scholar 

  36. I. Sakuma, D. Stuehr, S. S. Gross, C. Nathan, and R. Levi. Proc. Natl. Acad. Sci. USA 85:8664–8667 (1988).

    Google Scholar 

  37. U. Forstermann. J. Cardiovasc. Pharmacol. 8(Suppl. 10):S45–S51 (1986).

    Google Scholar 

  38. S. Moncada, M. W. Radomski, and R. M. J. Palmer. Biochem. Pharmacol. 37:2495–2501 (1988).

    Google Scholar 

  39. F. Murad, W. P. Arnold, C. K. Mittal, and J. M. Braughler. Adv. Cyclic Nucleotide Res. 11:175–204 (1979).

    Google Scholar 

  40. P. A. Craven and F. R. DeRubertis. J. Biol. Chem. 253:8433–8443 (1978).

    Google Scholar 

  41. C. A. Gruetter, D. Y. Gruetter, J. E. Lyon, P. J. Kadowitz, and L. J. Ignarro. J. Pharmacol. Exp. Ther. 219:181–186 (1981).

    Google Scholar 

  42. L. J. Ignarro, H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. J. Pharmacol. Exp. Ther. 218:739–749 (1981).

    Google Scholar 

  43. J. C. Edwards, L. J. Ignarro, K. S. Wood, A. L. Hyman, and P. J. Kadowitz. J. Pharmacol. Exp. Ther. 228:33–42 (1984).

    Google Scholar 

  44. B. T. Mellion, L. J. Ignarro, C. B. Myers, E. H. Ohlstein, B. A. Ballot, A. L. Hyman, and P. J. Kadowitz. Mol. Pharmacol. 23:653–664 (1983).

    Google Scholar 

  45. B. T. Mellion, P. M. Horwitz, A. L. Hyman, L. J. Ignarro, and P. J. Kadowitz. Fed. Proc. 41:1304 (1982).

    Google Scholar 

  46. D. J. Stuehr and M. A. Marletta. Proc. Natl. Acad. Sci. USA 82:7738–7742 (1985).

    Google Scholar 

  47. D. J. Stuehr and M. A. Marletta. J. Immunol. 139:518–525 (1987).

    Google Scholar 

  48. D. J. Stuehr and M. A. Marletta. Cancer Res. 47:5590–5594 (1987).

    Google Scholar 

  49. R. Iyengar, D. J. Stuehr, and M. A. Marletta. Proc. Natl. Acad. Sci. USA 84:6369–6373 (1987).

    Google Scholar 

  50. J. B. Hibbs, Z. Vavrin, and R. R. Taintor. J. Immunol. 138:550–565 (1987).

    Google Scholar 

  51. J. B. Hibbs, R. R. Taintor, and Z. Vavrin. Science 235:473–476 (1987).

    Google Scholar 

  52. J. B. Hibbs, R. R. Taintor, Z. Vavrin, and E. M. Rachlin. Biochem. Biophys. Res. Commun. 157:87–94 (1988).

    Google Scholar 

  53. U. Forstermann, U. Alheid, J. C. Frolich, and A. Mulsch. Br. J. Pharmacol. 93:569–578 (1988).

    Google Scholar 

  54. C. H. C. Twort and C. van Breemen. Circ. Res. 62:961–964 (1988).

    Google Scholar 

  55. T. L. Cornwell and T. M. Lincoln. J. Biol. Chem. 264:1146–1155 (1989).

    Google Scholar 

  56. L. J. Ignarro, K. S. Wood, B. Ballot, and M. S. Wolin. J. Biol. Chem. 259:5923–5931 (1984).

    Google Scholar 

  57. L. J. Ignarro, J. B. Adams, P. M. Horwitz, and K. S. Wood. J. Biol. Chem. 261:4997–5002 (1986).

    Google Scholar 

  58. R. Gerzer, E. Bohme, F. Hofmann, and G. Schultz. FEBS Lett. 132:71–74 (1981).

    Google Scholar 

  59. R. Gerzer, F. Hofmann, and G. Schultz. Eur. J. Biochem. 116:479–486 (1981).

    Google Scholar 

  60. E. H. Ohlstein, K. S. Wood, and L. J. Ignarro. Arch. Biochem. Biophys. 218:187–198 (1982).

    Google Scholar 

  61. L. J. Ignarro, K. S. Wood, and M. S. Wolin. Adv. Cyclic Nucleotide Prot. Phosphorylat. Res. 17:267–274 (1984).

    Google Scholar 

  62. M. S. Wolin, K. S. Wood, and L. J. Ignarro. J. Biol. Chem. 257:13312–13320 (1982).

    Google Scholar 

  63. L. J. Ignarro, B. Ballot, and K. S. Wood. J. Biol. Chem. 259:6201–6207 (1984).

    Google Scholar 

  64. L. J. Ignarro and P. J. Kadowitz. Annu. Rev. Pharmacol. Toxicol. 25:171–191 (1985).

    Google Scholar 

  65. S. C. Waldman and F. Murad. Pharmacol. Rev. 39:163–196 (1987).

    Google Scholar 

  66. L. J. Ignarro and C. A. Gruetter. Biochim. Biophys. Acta 631:221–231 (1980).

    Google Scholar 

  67. C. A. Gruetter, P. J. Kadowitz, and L. J. Ignarro. Can. J. Physiol. Pharmacol. 59:150–156 (1981).

    Google Scholar 

  68. P. Needleman and E. M. Johnson. J. Pharmacol. Exp. Ther. 184:709–715 (1973).

    Google Scholar 

  69. P. Needleman, B. Jakschik, and E. M. Johnson. J. Pharmacol. Exp. Ther. 187:324–331 (1973).

    Google Scholar 

  70. J. F. Brien, B. E. McLaughlin, T. H. Breedon, B. M. Bennett, K. Nakatsu, and G. S. Marks. J. Pharmacol. Exp. Ther. 237:608–614 (1986).

    Google Scholar 

  71. M. Feelisch and E. A. Noack. Eur. J. Pharmacol. 139:19–30 (1987).

    Google Scholar 

  72. M. Feelisch and E. A. Noack. Eur. J. Pharmacol. 142:465–469 (1987).

    Google Scholar 

  73. H.-L. Fung, S. Chong, E. Kowaluk, K. Hough, and M. Kakemi. J. Pharmacol. Exp. Ther. 245:524–530 (1988).

    Google Scholar 

  74. R. M. J. Palmer and S. Moncada. Biochem. Biophys. Res. Commun. 158:348–352 (1989).

    Google Scholar 

  75. I. J. Amber, J. B. Hibbs, R. R. Taintor, and Z. Vavrin. J. Leuk. Biol. 44:58–65 (1988).

    Google Scholar 

  76. G. Thomas and P. W. Ramwell. Biochem. Biophys. Res. Commun. 154:332–338 (1988).

    Google Scholar 

  77. G. Thomas and P. W. Ramwell. Eur. J. Pharmacol. 153:147–148 (1988).

    Google Scholar 

  78. G. Thomas, R. Mostaghim, and P. W. Ramwell. Biochem. Biophys. Res. Commun. 141:446–451 (1986).

    Google Scholar 

  79. L. J. Ignarro, M. E. Gold, G. M. Buga, R. E. Byrns, K. S. Wood, G. Chaudhuri, and G. Frank. Circ. Res. 64:315–329 (1989).

    Google Scholar 

  80. L. J. Ignarro. In R. Dulbecco (ed.), Encyclopedia of Human Biology, Academic Press, San Diego, (in press).

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, University of California, Los Angeles, California, 90024

    Louis J. Ignarro

Authors
  1. Louis J. Ignarro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ignarro, L.J. Endothelium-Derived Nitric Oxide: Pharmacology and Relationship to the Actions of Organic Nitrate Esters. Pharm Res 6, 651–659 (1989). https://doi.org/10.1023/A:1015926119947

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015926119947

Search

Navigation